Treatment News : Woman With Lupus Develops Powerful HIV Antibodies

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » March 2014

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

March 18, 2014

Woman With Lupus Develops Powerful HIV Antibodies

Scientists have discovered a woman with both lupus and HIV who has developed broadly neutralizing antibodies (BNAs) that have controlled her virus—findings that may help with HIV vaccine development, LiveScience reports. Publishing their findings in The Journal of Clinical Investigation, researchers studied a 33-year-old woman who was diagnosed with HIV at the age of 19 and lupus when she was 27.

In past research, the investigators had deduced that some HIV BNAs will attack the tissues of the body. They also noticed similarities between HIV BNAs and antibodies found in HIV-negative people with lupus. This suggested that HIV BNAs come from a pool of immune cells that can also lead to autoimmune disorders such as lupus.

HIV BNAs block the receptors the virus uses to latch onto human cells before infecting them. About one in five people with HIV will eventually produce BNAs, but they will largely do so too late: after the viral population has mutated enough to evade the antibodies’ effects.

Despite never having received antiretroviral treatment, the woman studied had a CD4 count of 568 and a viral load of 4,150.

The researchers hope that their study of this woman will help expand knowledge of the multiple ways that BNAs can be developed and ultimately aid in vaccine research. They caution that the study does not suggest that those with lupus are either immune to HIV or that those who are living with the virus in addition to lupus have a better prognosis than those without lupus.

To read the study, click here.

To read the LiveScience story, click here.

Search: Lupus, HIV, broadly neutralizing antibodies, BNAs, Journal of Clinical Investigation, vaccine.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]


Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    dhsd777
    san diego
    California


    TanyaB
    Delray Beach
    Florida


    youngbloodlatino
    Columbia
    Maryland


    robert12
    Queens
    New York
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Are you a regular coffee drinker?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.